View in EDS

560P Safety and efficacy of Debio 1143, an antagonist of inhibitor of apoptosis proteins (IAPs), in combination with nivolumab in a phase Ib/II trial in patients (pts) failing prior PD-1/PD-L1 treatment.

Saved in:
Bibliographic Details
Title: 560P Safety and efficacy of Debio 1143, an antagonist of inhibitor of apoptosis proteins (IAPs), in combination with nivolumab in a phase Ib/II trial in patients (pts) failing prior PD-1/PD-L1 treatment.
Authors: Pedrazzoli, A.B. Azaro1 (AUTHOR), Moreno, V.2 (AUTHOR), Gomez-Roca, C.A.3 (AUTHOR), Even, C.4 (AUTHOR), Cassier, P.5 (AUTHOR), Guerrero, T.C. Hernandez2 (AUTHOR), de Miguel, M.6 (AUTHOR), Korakis, I.3 (AUTHOR), Purcea, D.7 (AUTHOR), Roy, E.7 (AUTHOR), Gollmer, K.7 (AUTHOR), Riff, C.7 (AUTHOR), Szyldergemajn, S.A.7 (AUTHOR), Calvo, E.6 (AUTHOR)
Source: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS483-S483. 1p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2020.08.674